These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8588056)

  • 21. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
    Mandos LA; Rickels K; Cutler N; Roeschen J; Keppel Hesselink JM; Schweizer E
    Int Clin Psychopharmacol; 1995 Nov; 10(4):251-6. PubMed ID: 8748047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.
    Fresquet A; Sust M; Lloret A; Murphy MF; Carter FJ; Campbell GM; Marion-Landais G
    Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB; Wilcox CS
    Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of buspirone and diazepam in generalized anxiety disorder.
    Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM
    Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buspirone in depressed outpatients: a controlled study.
    Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
    Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the effect of two benzodiazepines in the treatment of anxious outpatients.
    de Figueiredo R; Franchini A; Martinho A; Hindmarch I
    Int Pharmacopsychiatry; 1981; 16(1):57-65. PubMed ID: 6117537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of buspirone to protect against lorazepam withdrawal symptoms.
    Jerkovich GS; Preskorn SH
    JAMA; 1987 Jul; 258(2):204-5. PubMed ID: 2885432
    [No Abstract]   [Full Text] [Related]  

  • 40. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.